(Reuters) - The panel urged FDA to request a post-approval study
comparing all patients treated with the CryoCor device and an
alternative treatment, Riley said.
The CryoCor product applies extreme cold via a catheter to
block electrical conduction in heart tissue. The company is
seeking FDA approval to sell the device for treating atrial
flutter, an abnormal beating of the heart's upper chambers.
Read more at Reuters.com Government Filings News
comparing all patients treated with the CryoCor device and an
alternative treatment, Riley said.
The CryoCor product applies extreme cold via a catheter to
block electrical conduction in heart tissue. The company is
seeking FDA approval to sell the device for treating atrial
flutter, an abnormal beating of the heart's upper chambers.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment